TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2350615

Group type: EXPERIMENTAL
Intervention: Pamidronate (1 mg/kg body wt.) by infusion over 4 h
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pamidronate (1 mg/kg body wt.) by infusion over 24 h
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups combined (n = 23)
Number of subjects: 25
Study: 7011531

Group type: EXPERIMENTAL
Intervention: POMP (prednisone, vincristine, methotrexate, and 6-mercaptopurine)
Number of subjects: 147

Group type: COMPARATOR
Intervention: PIP (6-mercaptopurine daily and a prednisone pulse every three months)
Number of subjects: 147
Study: 29914146

Group type: EXPERIMENTAL
Intervention: Quinoa-enriched bread (providing 20 g quinoa flour)
Number of subjects: 37

Group type: COMPARATOR
Intervention: 100% refined wheat bread
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Quinoa-enriched bread
Number of subjects: 37
Study: 27893654

Group type: EXPERIMENTAL
Intervention: Vaccine A
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Vaccine B
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Vaccine C
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Vaccine D
Number of subjects: 4000
Study: 24789668

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (low-intensity) for 18 months
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Composite lifestyle change (weight reduction of at least 5% and improvement in exercise capacity of at least 10%)
Number of subjects: 213
Study: 21895621

Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius plus fructo-oligosaccharide (synbiotic)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fructo-oligosaccharide (prebiotic)
Number of subjects: 60
Study: 20613470

Group type: EXPERIMENTAL
Intervention: Propofol (CePROP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Remifentanil (0, 2, and 4 ng/ml)
Number of subjects: 45
Study: 18806050

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) anesthesia
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sevoflurane-opioid anesthesia
Number of subjects: 72
Study: 16253965

Group type: EXPERIMENTAL
Intervention: GnRH agonist administration
Number of subjects: 1317

Group type: EXPERIMENTAL
Intervention: Cyst cycles
Number of subjects: 1317

Group type: EXPERIMENTAL
Intervention: Bilateral cysts
Number of subjects: 1317

Group type: COMPARATOR
Intervention: Cyst aspiration
Number of subjects: 1317
Study: 14508155

Group type: EXPERIMENTAL
Intervention: Antibiotic use and infection control practices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Third-generation cephalosporins, carbapenems, and fluoroquinolones
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extended-spectrum beta-lactamases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia
Number of subjects: 0
Study: 10685301

Group type: EXPERIMENTAL
Intervention: Prone-lying position
Number of subjects: 48

Group type: COMPARATOR
Intervention: Supine-lying position
Number of subjects: 48
Study: 7793587

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) - parenteral cefotaxime, oral and enteral polymyxin E, tobramycin, and amphotericin B
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 135
Study: 1726639

Group type: EXPERIMENTAL
Intervention: Acetohydroxamic acid (AHA)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 6992824

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30261171

Group type: EXPERIMENTAL
Intervention: Mothers with bonding difficulties
Number of subjects: 75

Group type: COMPARATOR
Intervention: Healthy mothers
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study: 28928556

Group type: COMPARATOR
Intervention: Inhalational anesthesia with isoflurane (Group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol (Group II)
Number of subjects: 60
Study: 25765348

Group type: EXPERIMENTAL
Intervention: 5% minoxidil topical foam (5% MTF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo foam (plaTF)
Number of subjects: 70
Study: 23764350

Group type: EXPERIMENTAL
Intervention: siponimod 0.25 mg
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: siponimod 0.5 mg
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: siponimod 1.25 mg
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: siponimod 2 mg
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: siponimod 10 mg
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control (placebo) for 6 months
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control (placebo) for 3 months
Number of subjects: 297
Study: 21187210

Group type: EXPERIMENTAL
Intervention: Isometric contractions (3 maximal voluntary contractions, 25% MVC held to task failure, 25% MVC held for 2 minutes)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Isometric contractions
Number of subjects: 15
Study: 19269254

Group type: EXPERIMENTAL
Intervention: Surgical decompression
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Surgical decompression (within 48 h of stroke onset)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 64
Study: 16900227

Group type: EXPERIMENTAL
Intervention: Endurance and resistance exercise plus nutritional counseling (EN)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nutritional counseling only (N)
Number of subjects: 12
Study: 15581196

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone (1 mg/daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11722323

Group type: EXPERIMENTAL
Intervention: Carbamazepine treatment (stable dose)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 9394975

Group type: EXPERIMENTAL
Intervention: Scratch-Monitor (SM) device
Number of subjects: 43

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study: 7651920

Group type: EXPERIMENTAL
Intervention: Early treatment with antiviral drugs
Number of subjects: 42
Study: 2956372

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diltiazem vs Propranolol
Number of subjects: 40
Study: 31584780

Group type: EXPERIMENTAL
Intervention: HP/TAZ lotion (halobetasol propionate 0.01% and tazarotene 0.045%)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: HP/TAZ lotion
Number of subjects: 62
Study: 28522311

Group type: EXPERIMENTAL
Intervention: Second appointment with fixed date and time (intervention)
Number of subjects: 26054

Group type: COMPARATOR
Intervention: Invitation letter with a telephone number to book a new appointment (control)
Number of subjects: 26054
Study: 26141044

Group type: EXPERIMENTAL
Intervention: Removable acrylic plates
Number of subjects: 65
Study: 24169346

Group type: EXPERIMENTAL
Intervention: Tivantinib 360 mg BID with erlotinib for extensive metabolisers (EMs)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tivantinib 240 mg BID with erlotinib for poor metabolisers (PMs)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Adverse events related to tivantinib and/or erlotinib (>20%, any grade)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pharmacokinetics profile of tivantinib
Number of subjects: 25
Study: 22087066

Group type: EXPERIMENTAL
Intervention: Calligraphy therapy (intensive calligraphy training for eight weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No calligraphy treatment (control group)
Number of subjects: 31
Study: 18724864

Group type: EXPERIMENTAL
Intervention: Non-surgical mechanical periodontal treatment in the second trimester of pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16413592

Group type: EXPERIMENTAL
Intervention: Trivalent live‐attenuated influenza virus vaccine (LAIV, FluMist)
Number of subjects: 56
Study: 15477795

Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs with renoprotective properties; specific types include angiotensin converting enzyme inhibitors, angiotensin receptor blockers, calcium antagonists, beta-blockers, and diuretics; dosage and duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable; control group not specified.
Number of subjects: 0
Study: 11229849

Group type: EXPERIMENTAL
Intervention: Candidate vaccines (low, medium, high doses)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Candidate vaccines
Number of subjects: 154

Group type: COMPARATOR
Intervention: Adjuvant
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control
Number of subjects: 154

Group type: COMPARATOR
Intervention: HIV-infected children
Number of subjects: 154
Study: 9308620

Group type: EXPERIMENTAL
Intervention: 6% dextran-70 (HSD)
Number of subjects: 1233

Group type: COMPARATOR
Intervention: 7.5% saline (HS)
Number of subjects: 1233
Study: 8483785

Group type: EXPERIMENTAL
Intervention: Preoxygenation (FiO2 = 1.0) via snug face mask for three minutes prior to lumbar puncture
Number of subjects: 21

Group type: COMPARATOR
Intervention: Room air (control group)
Number of subjects: 21
Study: 3324618

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg/48 hours) + dipyridamole (300 mg/day)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Dipyridamole (400 mg/day)
Number of subjects: 243
Study: 29417365

Group type: EXPERIMENTAL
Intervention: Enhanced nutrition services and education at five visits and one phone call between delivery and 6 months postpartum.
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard WIC services.
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups (Intervention and Control).
Number of subjects: 53
Study: 27329124

Group type: EXPERIMENTAL
Intervention: CHOP regimen
Number of subjects: 659

Group type: COMPARATOR
Intervention: CHOP-14 arm of JCOG9801
Number of subjects: 659
Study: 24001364

Group type: EXPERIMENTAL
Intervention: Guided Internet-delivered cognitive behavioural therapy (CBT) for insomnia over 6 weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 118
Study: 21986705

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (60,000 IU per month, equivalent to 2000 IU per day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 37
Study: 20840399

Group type: EXPERIMENTAL
Intervention: Integrated Cognitive Simulator (ICS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no ICS access)
Number of subjects: 58
Study: 18580407

Group type: EXPERIMENTAL
Intervention: Exercise trial (EX): 60‐min stationary cycle exercise (50% peak oxygen uptake) followed by 30‐min rest
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial (CON): 90‐min rest
Number of subjects: 8
Study: 16152839

Group type: EXPERIMENTAL
Intervention: Rhubarb and Sanchi Powder (RSP) - 3g of rhubarb and 2g of Sanchi Powder orally, 3-4 times daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dicynonum - 2g intravenously
Number of subjects: 60
Study: 12629246

Group type: EXPERIMENTAL
Intervention: Interferon beta-1b
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 11682582

Group type: EXPERIMENTAL
Intervention: 0.50 g of protein x kg(‐1) x day(‐1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 0.75 g of protein x kg(‐1) x day(‐1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1.00 g of protein x kg(‐1) x day(‐1)
Number of subjects: 11
Study: 9453274

Group type: EXPERIMENTAL
Intervention: Chocolate
Number of subjects: 63

Group type: COMPARATOR
Intervention: Carob (placebo)
Number of subjects: 63
Study: 7930384

Group type: EXPERIMENTAL
Intervention: Zinc therapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (age-matched)
Number of subjects: 110
Study: 2975291

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Isradipine 5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Isradipine 10 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Isradipine 20 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31342057

Group type: EXPERIMENTAL
Intervention: Outpatient parenteral antimicrobial therapy plus buprenorphine treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (inpatient intravenous antibiotic completion)
Number of subjects: 0
Study: 29099925

Group type: EXPERIMENTAL
Intervention: Adrenalectomy (ADX)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Mineralocorticoid receptor antagonists (MRAs)
Number of subjects: 184
Study: 27477896

Group type: EXPERIMENTAL
Intervention: Cx601 (120 million cells)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo (24 mL saline solution)
Number of subjects: 212
Study: 25900782

Group type: EXPERIMENTAL
Intervention: Remote Video Visits (VV)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Office Visits (OV)
Number of subjects: 55
Study: 23713304

Group type: EXPERIMENTAL
Intervention: Acupuncture at Jiaji (EX‐B 2) points combined with needling local myofascial trigger points (MTrP)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lidocaine injection at trigger points
Number of subjects: 66
Study: 20979574

Group type: EXPERIMENTAL
Intervention: HFE genotyping offered to participants
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Information on HFE‐HH provided to participants
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Assessment of signs and symptoms of hemochromatosis
Number of subjects: 221
Study: 18814407

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 mg Simvastatin (universal use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sitostanol/sitosterol products (whole population consumption)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5 mmol/L reduction in total cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.0 mmol/L reduction in total cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.5 mmol/L reduction in total cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.0 mmol/L reduction in total cholesterol
Number of subjects: 0
Study: 16800101

Group type: EXPERIMENTAL
Intervention: Generic abacavir (Ranbaxy‐Abacavir)
Number of subjects: 80
Study: 14710099

Group type: EXPERIMENTAL
Intervention: Cervical cerclage (McDonald cerclage suture)
Number of subjects: 150
Study: 11147929

Group type: EXPERIMENTAL
Intervention: G(‐463)A polymorphism of myeloperoxidase (MPO) gene
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Specific genotypes of cytochrome P4502D6
Number of subjects: 108

Group type: COMPARATOR
Intervention: Statistical analysis of genetic determinants
Number of subjects: 108
Study: 8629631

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 10
Study: 1464895

Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trandolapril 4 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trandolapril 8 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trandolapril (2, 4, 8 mg)
Number of subjects: 24
Study: 31403812

Group type: EXPERIMENTAL
Intervention: Only the husband received support from the wife
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Only the wife received support from the husband
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both received support
Number of subjects: 98

Group type: COMPARATOR
Intervention: Neither spouse received support
Number of subjects: 98
Study: 28668774

Group type: EXPERIMENTAL
Intervention: Initial serum lactate level
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Modified SOFA (mSOFA) score
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Normalization of lactate
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Initial pH
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Early positive blood cultures
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Repeat lactate ≥ 5 mmol/L
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: mSOFA score
Number of subjects: 410
Study: 26891150

Group type: EXPERIMENTAL
Intervention: 20% human albumin (100, 200, or 300 ml based on preoperative serum albumin level)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (equal volume of saline)
Number of subjects: 220
Study: 25397358

Group type: EXPERIMENTAL
Intervention: Serostatus disclosure
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Men who have sex with men (MSM)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 242
Study: 22860502

Group type: EXPERIMENTAL
Intervention: Polyurethane safety cannulae at -10 degrees C, 21 degrees C, and 40 degrees C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Teflon safety cannulae at -10 degrees C, 21 degrees C, and 40 degrees C
Number of subjects: 0
Study: 19653067

Group type: EXPERIMENTAL
Intervention: Normal calorie Red Bull
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low calorie Red Bull
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Red Bull consumption
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Red Bull consumption during cold pressor test (CPT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (normal calorie and low calorie)
Number of subjects: 68
Study: 17625023

Group type: EXPERIMENTAL
Intervention: Community health promotion campaign and contracted healthcare services; includes health education, training of health workers, and subsidized access to pregnancy-related healthcare services at non-public health centres.
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (no intervention); villages serving as controls for comparison.
Number of subjects: 464
Study: 16354520

Group type: EXPERIMENTAL
Intervention: Silicone ring length of 62 mm (group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Silicone ring length of 77 mm (group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: LES hypotonia (mean respiratory pressure <14 mmHg)
Number of subjects: 80
Study: 12383062

Group type: EXPERIMENTAL
Intervention: Rizatriptan
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 10216905

Group type: EXPERIMENTAL
Intervention: Filtered red-cell packs
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Filtered units
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Plasma units
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cold hold units
Number of subjects: 72

Group type: COMPARATOR
Intervention: Plasma storage parameters
Number of subjects: 72
Study: 7781725

Group type: EXPERIMENTAL
Intervention: Static magnetic field exposure from bonded samarium-cobalt magnets (100-150 Gauss for dental pulp, 200-900 Gauss for gingival tissues)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Demagnetized magnet (control)
Number of subjects: 7
Study: 2077596

Group type: EXPERIMENTAL
Intervention: Bupivacaine 4 degrees C
Number of subjects: 66

Group type: COMPARATOR
Intervention: Bupivacaine 20 degrees C
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Bupivacaine 37 degrees C
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Epidural injection of saline at 37 degrees C
Number of subjects: 66

Group type: COMPARATOR
Intervention: Self-limited tremor
Number of subjects: 66
Study: 231324

Group type: EXPERIMENTAL
Intervention: Phanurane (2 gelules daily, 2 X 50 mg of canrenone)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 29510613

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 56
Study: 28192854

Group type: EXPERIMENTAL
Intervention: TRP agonist
Number of subjects: 39

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 39
Study: 25734870

Group type: EXPERIMENTAL
Intervention: Parenting group intervention (N=34)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Health focused control group (N=46)
Number of subjects: 80
Study: 23621350

Group type: EXPERIMENTAL
Intervention: 20 μg rBet v 1‐FV
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 80 μg rBet v 1‐FV
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 160 μg rBet v 1‐FV
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 320 μg rBet v 1‐FV
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 22185606

Group type: EXPERIMENTAL
Intervention: Individual hypnotherapy (6 sessions)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Group hypnotherapy (6 sessions)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Educational supportive therapy in a group (placebo, 6 sessions)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Individual hypnotherapy
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Group hypnotherapy
Number of subjects: 354

Group type: COMPARATOR
Intervention: Educational supportive therapy in a group (placebo)
Number of subjects: 354
Study: 19422286

Group type: EXPERIMENTAL
Intervention: BEMER magnetic field treatment for 8 minutes twice daily for 12 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 37
Study: 16769944

Group type: EXPERIMENTAL
Intervention: Andersen-Tawil syndrome (ATS) subjects
Number of subjects: 20
Study: 15019375

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% and timolol 0.5% once daily
Number of subjects: 253

Group type: COMPARATOR
Intervention: Dorzolamide 2% and timolol 0.5% twice daily
Number of subjects: 253
Study: 11393598

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Exposure and response prevention (ERP)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control condition (wait-list)
Number of subjects: 76
Study: 9251276

Group type: EXPERIMENTAL
Intervention: Exchange transfusion (ET)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No exchange transfusion (controls)
Number of subjects: 40